Dr. Michael Lapelusa, MD

  • Houston, TX
  • Internist
NPI1831728401PAC ID6305261215
Part D claims, 2024
21
Publications
18
Hospital affiliations
1
Industry payments
$962
Medical group
1
Practice address
1515 Holcombe Blvd, Houston, TX 77030
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Find Dr. Lapelusa's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Michael Lapelusa is an internist in Houston, Texas

Dr. Lapelusa practices at The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System.

Dr. Lapelusa's NPI, 1831728401, was assigned on April 6, 2020. Dr. Lapelusa graduated from University of Texas Rio Grande Valley School of Medicine in 2020. Dr. Lapelusa's Texas license number on file is V0455.

NPI and contact details
Medicare PAC ID
6305261215
NPI enumeration date
April 6, 2020
NPI status
Active
Accepts Medicare assignment
Yes
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Medical school graduation
2020

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Michael Lapelusa practices at The University of Texas MD Anderson Cancer Center in Houston, Texas

Dr. Lapelusa's primary practice is The University of Texas MD Anderson Cancer Center, at 1515 Holcombe Blvd, Houston, TX 77030.

Sources: Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Michael Lapelusa is affiliated with 1 site of care and 1 medical group

Dr. Lapelusa's primary practice is The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System. The medical group on file is Physicians Referral Service.

Sources: Dmand AI Affiliation Data; Doctors and Clinicians National Downloadable File (CMS); and Dmand AI Org Hierarchy Data

Dmand AI tracks the EHR system at Dr. Michael Lapelusa's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lapelusa practices. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
The University of Texas MD Anderson Cancer CenterAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every hospital where Dr. Lapelusa practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across The University of Texas System and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Michael Lapelusa is one of 8,437 internists in Texas

Internal medicine is Dr. Lapelusa's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Lapelusa is board certified in internal medicine by the American Board of Internal Medicine. Dr. Lapelusa has a license on file in Texas.

Specialties and state licenses

  • Internal medicine, TexasPrimaryLicense V0455 · 2024 to 2025 · taxonomy 207R00000X

Internists near Dr. Lapelusa

Counts of internists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Michael Lapelusa's patients have a median age of 64

Across all payers, Dmand AI patient panel data puts Dr. Lapelusa's median patient age at 64, with 0% women.

Dr. Lapelusa's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 64

Patient panel by sex, all payers

  • Women0%
  • Men100%

Source: Dmand AI Patient Panel Data

Dr. Michael Lapelusa wrote 21 Medicare Part D claims in 2024

In 2024, Dr. Lapelusa wrote 21 Medicare Part D claims for 12 patients. 95% of them were for generic drugs. They cover 7 drugs, with $2,772 in total drug cost. In 2022, CMS named 238 claims across 13 drugs.

Part D claims, 202421
Drugs named by CMS7
Total drug cost$2,772
Part D patients12

Dr. Lapelusa's Part D claims by kind of drug, 2024

  • Generic20 claims95%
  • Brand-name and other1 claims5%

Dr. Lapelusa's most prescribed drugs by claims, 2023

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Part D claims for drugs CMS names, 2022 to 2023

  • 2022
  • 2023
Claims for drugs CMS names
2022: 2382023: 12547%

Drugs named by CMS: 7 in 2023, 13 in 2022.

See all prescribing by Dr. Lapelusa

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

How Dr. Michael Lapelusa takes part in Medicare

Dr. Lapelusa accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Accepts Medicare assignment
Yes

Source: Doctors and Clinicians National Downloadable File (CMS)

For MedTech and pharma teams

Find internists like Dr. Lapelusa by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Michael Lapelusa has 18 publications on record

Dmand AI links 18 papers to Dr. Lapelusa, published from 2021 to 2025. 2023 was the busiest year, with 5. The most frequent topics are Colorectal Neoplasms, Biomarkers, Tumor and Circulating Tumor DNA. Dr. Lapelusa has published most often in Cancers (Basel). Dr. Lapelusa's most frequent co-authors are Ahmed O. Kaseb, MD, Sunyoung S. Lee, MD and Hesham M. Amin, MD.

Papers18
Years published2021 to 2025

Dr. Lapelusa's papers by year, 2021 to 2025

Topics Dr. Lapelusa writes about most

  • Colorectal Neoplasms
  • Biomarkers, Tumor
  • Circulating Tumor DNA
  • Neoadjuvant Therapy

Dr. Lapelusa's most frequent co-authors

Recent publications by Dr. Lapelusa

See all 18 publications and co-authors

See who Dr. Lapelusa researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Lapelusa works with, so you can find a warm path to the right internists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Michael Lapelusa received $962 in industry payments from 2023 to 2025

CMS Open Payments shows 19 general payments to Dr. Lapelusa from 12 drug and device companies from 2023 to 2025. Food and beverage make up the largest share, 100% of the total. Pfizer Inc. paid the most, $338.

General payments to Dr. Lapelusa by program year, 2023 to 2025

Companies that paid Dr. Lapelusa the most, 2023 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Lapelusa

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. Michael Lapelusa graduated from University of Texas Rio Grande Valley School of Medicine

Dr. Lapelusa graduated from University of Texas Rio Grande Valley School of Medicine in 2020.

  1. Medical schoolUniversity of Texas Rio Grande Valley School of Medicine
  2. Board certified in internal medicineAmerican Board of Internal Medicine

Source: Dmand AI Professional Profile Data

Dr. Michael Lapelusa accepts plans from 3 insurance carriers

Dr. Lapelusa is in network with 3 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 3. Check the plan with the practice before a visit.

  • Elevance
  • Aetna
  • Blue Cross Blue Shield of Michigan

Plan types Dr. Lapelusa accepts, by number of carriers

  1. HMO3
  2. POS3
  3. PPO3
  4. EPO2
  5. Medicare1

Source: Dmand AI Insurance Network Data

Sources for Dr. Michael Lapelusa's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneDmand AI Affiliation DataDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)
Primary practice, affiliations and health systemDmand AI Affiliation DataDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Dmand AI Org Hierarchy Data
Medicare patients and the all-payer patient panelDmand AI Patient Panel Data
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Training, board certification and membershipsDmand AI Professional Profile Data
Insurance carriers and plan typesDmand AI Insurance Network Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Michael Lapelusa

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Michael Lapelusa's NPI number?

Dr. Michael Lapelusa's NPI number is 1831728401. It was assigned on April 6, 2020, and it is active in the NPI Registry.

What kind of doctor is Dr. Michael Lapelusa?

Dr. Michael Lapelusa is an internist in Houston, Texas. The primary specialty in the NPI Registry is Internal Medicine Physician (taxonomy code 207R00000X).

Where does Dr. Michael Lapelusa practice?

Dr. Lapelusa practices at 1515 Holcombe Blvd, Houston, TX 77030. Dr. Lapelusa's primary practice is The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System.

What is Dr. Michael Lapelusa's medical license number?

Dr. Lapelusa's Texas license number on file is V0455.

Which hospitals is Dr. Michael Lapelusa affiliated with?

Dr. Lapelusa practices at The University of Texas MD Anderson Cancer Center in Houston, Texas.

What medical group is Dr. Michael Lapelusa part of?

Dr. Lapelusa is linked to Physicians Referral Service.

Does Dr. Michael Lapelusa accept Medicare?

Yes. CMS lists Dr. Lapelusa as accepting Medicare assignment.

Is Dr. Michael Lapelusa board certified?

Yes. Dr. Lapelusa is board certified in internal medicine by the American Board of Internal Medicine.

Where did Dr. Michael Lapelusa go to medical school?

Dr. Lapelusa graduated from University of Texas Rio Grande Valley School of Medicine in 2020.

What drugs does Dr. Michael Lapelusa prescribe most?

In 2023 Medicare Part D data, Dr. Lapelusa's most prescribed drugs by claims were Atorvastatin Calcium, Amlodipine Besylate and Fluticasone Propionate.

Show 5 more questionsShow fewer questions

Has Dr. Michael Lapelusa received payments from drug or device companies?

CMS Open Payments shows $962 in general payments to Dr. Lapelusa from 12 companies from 2023 to 2025. The largest total came from Pfizer Inc.

How long has Dr. Michael Lapelusa been practicing?

Dr. Lapelusa graduated from medical school in 2020, 6 years ago.

Does Dr. Michael Lapelusa do research?

Dmand AI links 18 publications to Dr. Lapelusa, published from 2021 to 2025.

Who does Dr. Michael Lapelusa publish with?

Dr. Lapelusa's most frequent co-authors are Ahmed O. Kaseb, MD (6 shared papers), Sunyoung S. Lee, MD (5 shared papers) and Hesham M. Amin, MD (4 shared papers).

What insurance does Dr. Michael Lapelusa accept?

Dr. Lapelusa is in network with 3 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 3. Check the plan with the practice before a visit.

Selling to internal medicine practices?

See internists in Texas by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)